Clinical Trial Update: Study of the Safety of MDX-1342 in Combination With Methotrexate in Patients With Rheumatoid Arthritis [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluated the safety of MDX-1342 in combination with methotrexate in patients with rheumatoid arthritis. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• MDX-1342
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Rheumatoid Arthritis | Phase 1 | Status: COMPLETED